Balyasny Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-75,089
Closed -$407K 2152
2025
Q1
$407K Sell
75,089
-148,552
-66% -$805K ﹤0.01% 1626
2024
Q4
$1.67M Buy
223,641
+156,568
+233% +$1.17M ﹤0.01% 1141
2024
Q3
$536K Sell
67,073
-49,122
-42% -$392K ﹤0.01% 1520
2024
Q2
$1.01M Buy
+116,195
New +$1.01M ﹤0.01% 1238